Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |